Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2009
08/26/2009EP2093228A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
08/26/2009EP2091970A2 Inhibition of platelet aggregation
08/26/2009EP2091940A2 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
08/26/2009EP2091917A1 Ion channel modulators
08/26/2009EP2091539A1 Ambrisentan combined with a renin inhibitor for hypertensive disorder
08/26/2009EP2091537A1 Pharmaceutical compositions for the treatment of capillary arteriopathy
08/26/2009EP2091534A1 Azetidinone derivatives and methods of use thereof
08/26/2009EP2091531A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt
08/26/2009EP1911746B1 The substance having antioxidant, geroprotective and anti-ischemic activity and method for preparing thereof
08/26/2009EP1537875B1 C-terminal globular domain of adiponectin for use in the treatment of arteriosclerosis
08/26/2009EP1506951B9 Method for the preparation of total salvianolic acid
08/26/2009EP1496929A4 Use of c5a receptor antagonist in the treatment of fibrosis
08/26/2009EP1328279B1 Compositions comprising lignin and methods of making and using the same
08/26/2009EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives
08/26/2009EP1061812B1 Food products having enhanced cocoa polyphenol content and processes for producing same
08/26/2009EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
08/26/2009CN101516893A Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derevatives and their use in therapy
08/26/2009CN101516890A Diaryl ketimine derivative
08/26/2009CN101516888A Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use
08/26/2009CN101516873A Indazolyl derivatives useful as potassium channel modulating agents
08/26/2009CN101516864A Process for the preparation of candesartan cilexetil form I
08/26/2009CN101516838A Soluble epoxide hydrolase inhibitors
08/26/2009CN101516826A Beta-3 receptor ligands and their use in therapy
08/26/2009CN101516385A Treatment of excessive neovascularization
08/26/2009CN101516380A Composition capable of reducing blood pressure and/or suppressing rise in blood temperature and drink containing same
08/26/2009CN101516361A Soluble epoxide hydrolase inhibitors
08/26/2009CN101514355A Method for preparing wheat germ protein ACE inhibitory peptide by continuous enzymolysis and ultra-filtration separation coupling
08/26/2009CN101514180A Perindopril tert-butylamine salt crystal I and method for preparing same
08/26/2009CN101514177A Method for extracting lutein from marigold particles
08/26/2009CN101513533A Method for building models of various diseases in one rat body and application thereof
08/26/2009CN101513513A Chinese medicine pill for treating cardiovascular and cerebrovascular disease
08/26/2009CN101513512A Drug for cardiac care and coronary heart disease treatment
08/26/2009CN101513505A Capsule used for curing cardiovascular and cerebrovascular diseases
08/26/2009CN101513501A Composition capable of comprehensively restoring cardio and cerebral circulation systems and preparation method thereof
08/26/2009CN101513491A Chinese medicine for treating cardiovascular and cerebrovascular diseases
08/26/2009CN101513478A External application ointment for treating III stage angiitis
08/26/2009CN101513476A Chinese medicinal composition for treating cerebrovascular diseases, and preparation method thereof
08/26/2009CN101513461A A pill for treating cerebral apoplex and the sequela thereof
08/26/2009CN101513452A Decumbent corydalis tuber cataplasm and preparation method thereof
08/26/2009CN101513449A Salvia miltiorrhiza emulsion for coronary disease and preparation method thereof
08/26/2009CN101513448A Preparation and use of Ziziphora general lavone
08/26/2009CN101513432A Preparation and new usage of selaginella tamariscina biflavone ingredient
08/26/2009CN101513389A Oral puerarin nano suspension for improving bioavailability of puerarin
08/26/2009CN101513386A Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
08/26/2009CN101513255A Black sesame dessert for lowering blood pressure
08/26/2009CN100532375C Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical containing the compound
08/26/2009CN100532356C Sodium sulfonate substituted diphenyl heptane compound, and preparation method, and application
08/26/2009CN100532349C Preparation of phenols difluoro heptane compound, and its oxidation resistant application
08/26/2009CN100531797C Novel use of erythropoietin in heart diseases
08/26/2009CN100531796C FGFR agonists
08/26/2009CN100531794C Compositions and methods for modifying toxic effects of protein compounds
08/26/2009CN100531765C Pinellia tuber extract and its preparation process, medicine composition and use
08/26/2009CN100531740C Health care products for auxiliary treatment of diseases of cardio-cerebral blood vessels
08/26/2009CN100531737C Huangyangning dispersion tablets and preparation process
08/26/2009CN100531723C Calf serum protein-removing extract for injection and its preparation method
08/26/2009CN100531587C A processing method of ginkgo flower tea
08/26/2009CN100531584C Fat-control tea
08/25/2009US7579494 Prevention of neutrophil recruitment
08/25/2009US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia
08/25/2009US7579435 Somatostatin-dopamine chimeric analogs
08/25/2009US7579432 Cyclic peptides as G-protein-coupled receptor antagonists
08/25/2009US7579379 bis-[2-(pivaloylamino)phenyl]disulfide; cholesteryl ester transfer protein (CETP); atherosclerosis, hyperlipidemia
08/25/2009US7579377 Use of adapalene or salt thereof to treat skin disorders having an inflammatory or proliferative component such as acne or psoriasis; dosage forms
08/25/2009US7579367 Aryl substituted pyridines and the use thereof
08/25/2009US7579354 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro- 1H-purin-8-yl)- bicyclo[2.2.2]oct-1-yl]-propionic acid or pharmaceutically acceptable salts; highly potent and selective diuretics; treatment of cardiac and circulatory disorders, degenerative disorders of central nervous system
08/25/2009US7579347 Vanilloid receptor ligands and their use in treatments
08/25/2009US7579346 Carboxamides
08/25/2009US7579342 Pteridine compounds for the treatment of psoriasis
08/25/2009US7579339 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use
08/25/2009US7579327 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators
08/25/2009US7579325 Drugs containing reduced of vitamin B2
08/25/2009US7579322 Compositions and methods for promoting myocardial and peripheral angiogenesis
08/25/2009US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof
08/25/2009US7579166 lysosomal enzyme having a mannose-6-phosphate-containing acidic sugar chain; a labeling marker for transporting into lysosomes; used as a drug effective in treatment of human lysosomal enzyme deficiencies
08/25/2009US7578784 Cardiac support device with differential expansion
08/25/2009CA2474578C Novel pyridin- and pyrimidin-derivatives
08/25/2009CA2439078C Composition improving age-related physiological deficits and increasing longevity
08/25/2009CA2426936C Oral preparation containing seaweed for reduction of plaque and calculus
08/25/2009CA2405172C Alpha,beta-unsaturated sulfones for treating proliferative disorders
08/25/2009CA2394794C Methods for preparing pharmaceutical formulations
08/25/2009CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds
08/25/2009CA2375671C 4-phenyl-pyrimidine derivatives
08/25/2009CA2366932C Cyclic protein tyrosine kinase inhibitors
08/25/2009CA2215356C Novel embolizing compositions
08/25/2009CA2099541C Cyclic adhesion inhibitors
08/20/2009WO2009102966A2 Bmp-7 for use in treating vascular sclerosis
08/20/2009WO2009102886A1 Use of ranolazine for the treatment of cardiovascular diseases
08/20/2009WO2009102771A1 Methods of converting polymorphic form b of bazedoxifene acetate to polymorphic form a of bazedoxifene acetate
08/20/2009WO2009102450A1 Egg products with components recognized for reducing the levels of cholesterol in people and/or improving their health
08/20/2009WO2009101968A1 Anti-adam-15 antibodies and utilization of the same
08/20/2009WO2009101956A1 Novel substance fki-3864 and method for production thereof
08/20/2009WO2009101812A1 Glutamic acid transporter inhibitor
08/20/2009WO2009101131A1 Treating hypertension with 25-hydroxyvitamin d3
08/20/2009WO2009101092A1 Farp2 and stk25 and uses thereof
08/20/2009WO2009100827A1 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and use thereof
08/20/2009WO2009100617A1 Polypeptide inhibiting angiogenesis and applicaton thereof
08/20/2009WO2009100591A1 Use of hydrochloric acid for the manufacture of medicine in treating vascular disease
08/20/2009WO2009100534A1 Combination therapy to treat vascular disorders
08/20/2009WO2009100530A1 Uses of modified elr-cxc chemokine g31p
08/20/2009WO2009076580A3 Compositions and methods for the treatment and prevention of cardiovascular diseases